The research objective of this article is to explore the effectiveness evaluation of the combination of general and specialized departments in the management of chronic obstructive pulmonary disease (COPD) in the community. The research method of this article is as follows:80 patients with COPD in stable stage who signed a family doctor from July to December, 2022 were randomly divided into general management group (control group) and full-time management group (observation group). The general management group implemented the routine chronic disease management mode of general medical follow-up. The full-time management group implements the joint management of chronic obstructive pulmonary disease by general practitioners and specialties. Six months after the implementation of different management modes, the lung function index, dyspnea degree and symptom score, anxiety and depression score, the number of acute attacks and patient satisfaction were compared between the two groups. After 6 months of intervention, there were no lost cases in both groups. The improvement of lung function, dyspnea degree and symptom score, anxiety and depression score and patient satisfaction in the observation group were better than those in the control group, and there was no significant difference in the number of acute attacks between the two groups. The combination of full-time and full-time management of COPD is effective and can be further promoted.

Miao Li, Yan Rui, Rongxin Wang, Changhong Sun, Qingyu Yang. Evaluation of the Effect of the “General Practitioner-Specialist” Combination in the Community Management of Chronic Obstructive Pulmonary Disease. Frontiers in Medical Science Research (2024), Vol. 6, Issue 2: 126-132. https://doi.org/10.25236/FMSR.2024.060219.

[1] Ting-Ting Wu,Yi Qun Jiang, Bang-Feng Zhao, et al. Real-World COPD Management Over 3 Years at the Community Health Service Center of Shanghai During the COVID-19 Pandemic in China[J]. International Journal of Chronic Obstructive Pulmonary Disease, 2023(18): 349-364.

[2] Hongjia Song,Lujing Jiang,Wanchun Yang,et al. Cryptotanshinone alleviates lipopolysaccharide and cigarette smoke-induced chronic obstructive pulmonary disease in mice via the Keap1/Nrf2 axis[J].Biomed Pharmacother, 2023(165):115105.

[3] Shuang Qu, Jing Zhu. A Nomogram for Predicting Cardiovascular Diseases in Chronic Obstructive Pulmonary Disease Patients[J].Journal of Healthcare Engineering,2022: 6394290.

[4] Xia Liu, Xiaojing Jiao, Xiaowei Gong,et al. Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study[J].International Journal of Chronic Obstructive Pulmonary Disease,2023(18):907-917.

[5] IngmarBergs, KatjaSJust, CatharinaScholl,et al. Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations[J].European Journal of Clinical Pharmacology, 2023(79):219–227.

[6] Xiaofang Zheng, Dandan Chen, Xiaoling Zhu, et al. Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation[J].Pharmacol Res Perspect, 2021,9(4):e00840.

[7] Notice of the National Health Commission on Doing a Good Job in Basic Public Health Service Projects in 2020http://www.nhc.gov.cn/cms-search//xxgk/getManuscriptxxgk.htm.

[8] Chen Mingmin, Ye Kangli, Xu Zhijie, et al. Current Status and Prospects of Community Management of Chronic Obstructive Pulmonary Disease in China [J]. General Practitioner Medicine in China, 2020(03):251-256.

[9] Zhuo Jiaxing, Zhao Taihong. Progress and Strategy Optimization of Health Management Models Based on Chronic Obstructive Pulmonary Disease at Home and Abroad [J]. Health Soft Science, 2022, 36(2):88-93.

[10] Pan Zihan, Chi Chunhua, Zheng Jiaqiang. Research status of screening methods for chronic obstructive pulmonary disease in primary medical institutions [J]. General practice medicine in China, 2020, 23(3):257-266.

[11] Liang Zhenyu, Wang Fengyan, Chen Zizheng, et al. Interpretation of Key Points of Global Strategy Update for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease by GOLD [J]. Chinese General Practitioner Medicine, 2023,26(11):1287-1298.

[12] Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmo nary disease 2020 report[EB/OL]. https: / / goldcopd. org /gold- reports/, 2019-11-06 /2019 -12-15.

[13] Halil Ibrahim Toy, Abdullah Burak Yildiz,Demet Tasdemir Kahraman,et al. Capsaicin suppresses ciliary function, while inducingpermeability in bronchial epithelial cell cultures of COPD patients[J].Frontiers in Pharmacology, 2022,13:996046.

[14] Chan K Y, Li X, Chen W J, et al. Prevalence of chronic obstructive pulmonary disease(COPD)in China in 1990 and 2010 [J]. J Glob Health, 2017,7(2): 020704.

[15] Hui Lin, Jianhong Xiao, Xianghua Su, et al. The Association Between Serum Human Epididymis Protein 4 Level and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease[J]. Laboratory Medicine, 2021, 52(3):260-266.

[16] Xu Dandan, Yang Tao, Yang Jing. A study on the therapeutic effect of the "family hospital bed" management model on stable chronic obstructive pulmonary disease patients in the community [J]. Journal of Tongji University, 2023, 44(2):252-258.